{"title":"Retrospective Analysis of Demographic and Laboratory Data of Patients with Hepatocellular Carcinoma: Single Center Experience","authors":"M. Bardakci, Y. Ergun, K. Yalcin","doi":"10.5505/AOT.2019.69672","DOIUrl":"https://doi.org/10.5505/AOT.2019.69672","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130304155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sabin Göktaş Aydın, Ö. Açıkgöz, Yasin Kutlu, A. Bilici, J. Hamdard, Ö. Ölmez, Özcan Yıldız
{"title":"Real-life analysis of immunotherapy as the second or later lines treatment in patients with metastatic non-small cell lung cancer","authors":"Sabin Göktaş Aydın, Ö. Açıkgöz, Yasin Kutlu, A. Bilici, J. Hamdard, Ö. Ölmez, Özcan Yıldız","doi":"10.5505/aot.2021.26576","DOIUrl":"https://doi.org/10.5505/aot.2021.26576","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"111 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132186840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Duran, A. Ant, Tuncay Tunccan, C. Kılıç, Elif Akyol Şen, Burcu Vural, Samet Özlügedik
{"title":"The impact of the COVID-19 pandemic on head and neck cancer practice - tertiary health care center experience","authors":"A. Duran, A. Ant, Tuncay Tunccan, C. Kılıç, Elif Akyol Şen, Burcu Vural, Samet Özlügedik","doi":"10.5505/aot.2021.46762","DOIUrl":"https://doi.org/10.5505/aot.2021.46762","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129567749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Survival of a Patient with Anaplastic Thyroid Cancer Following Neoadjuvant Chemotherapy Regimen ‘cisplatin doxorubicin’ And Surgery - A Case Report","authors":"G. Akgul, E. Esen, I. Erturk, M. Turan, M. Akıncı","doi":"10.5505/AOT.2020.49932","DOIUrl":"https://doi.org/10.5505/AOT.2020.49932","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"479 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132219185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bedriye Busra Demirel, S. Gülbahar Ateş, Hüseyin Emre Tosun, Süleyman Aksu, Gülin Uçmak
Introduction: We aimed to investigate the relationship between staging FGD PET/CT findings and metastasis distribution and histopathological features of primary tumor in patients with metastatic breast cancer at diagnosis time. Materials and Methods: Eighty patients with breast cancer who underwent F-18 FDG PET/CT for staging were included. The patients with newly diagnosed metastatic disease were included. Age and histopathological features of the primary tumor were recorded. The distant metastases sites, the numbers of metastasis and metastatic axillary/non-axillary lymph nodes were reviewed from PET/CT. The maximum standardized uptake(SUVmax) values were measured. Results: All patients(n:80,mean age 58.0±14.4) had invasive breast carcinoma. Age was significantly related to the presence of lung metastases(p=0.006, mean ages 54y vs 64y).Only liver metastasis had a significant relationship with primary tumor SUVmax values and tumor molecular profile. The patients with HR+/HER2-(7/60 patients, 11.7%) had relatively less liver metastasis than with the other subtypes (9/20patients, 45%). There were significant associations between SUVmax of axillary lymph node(p=0.02), primary tumor(p=0.001), liver metastasis(p=0.02) and tumor subtypes. The numbers of distant metastasis were related with the numbers of axillary lymph node metastasis(p=0.02) and the highest SUVmax of distant metastasis(p=0.001). Discussion: Accurate detection of distant metastases in breast cancer at the time of diagnosis is of great importance in terms of treatment planning and prognosis of the disease. FDG PET/CT is a very reliable modality in determining distant metastasis and their distribution, and as a result of our study, we suggest that PET/CT findings can predict factors with prognostic importance.
前言:我们旨在探讨转移性乳腺癌患者诊断时FGD分期PET/CT表现与原发肿瘤转移分布及组织病理学特征的关系。材料与方法:80例接受F-18 FDG PET/CT分期的乳腺癌患者。包括新诊断的转移性疾病患者。记录原发肿瘤的年龄和组织病理学特征。PET/CT检查远处转移部位、转移数量及腋窝/非腋窝淋巴结转移情况。测量了最大标准化摄取(SUVmax)值。结果:80例患者均为浸润性乳腺癌，平均年龄58.0±14.4岁。年龄与肺转移的存在显著相关(p=0.006，平均年龄54y vs 64y)。只有肝转移与原发肿瘤SUVmax值和肿瘤分子谱有显著关系。HR+/HER2-亚型患者(7/60例，11.7%)的肝转移率低于其他亚型患者(9/20例，45%)。腋窝淋巴结SUVmax (p=0.02)、原发肿瘤(p=0.001)、肝转移(p=0.02)与肿瘤亚型有显著相关性。远处转移数与腋窝淋巴结转移数相关(p=0.02)，远处转移SUVmax最高(p=0.001)。讨论:在诊断时准确发现乳腺癌远处转移对疾病的治疗计划和预后具有重要意义。FDG PET/CT是确定远处转移及其分布的一种非常可靠的方式，根据我们的研究，我们认为PET/CT的结果可以预测具有预后重要性的因素。
{"title":"Relationship Between Staging FDG PET/CT Findings and Distribution of Metastatic Sites in Metastatic Breast Cancer","authors":"Bedriye Busra Demirel, S. Gülbahar Ateş, Hüseyin Emre Tosun, Süleyman Aksu, Gülin Uçmak","doi":"10.5505/aot.2023.40360","DOIUrl":"https://doi.org/10.5505/aot.2023.40360","url":null,"abstract":"Introduction: We aimed to investigate the relationship between staging FGD PET/CT findings and metastasis distribution and histopathological features of primary tumor in patients with metastatic breast cancer at diagnosis time. Materials and Methods: Eighty patients with breast cancer who underwent F-18 FDG PET/CT for staging were included. The patients with newly diagnosed metastatic disease were included. Age and histopathological features of the primary tumor were recorded. The distant metastases sites, the numbers of metastasis and metastatic axillary/non-axillary lymph nodes were reviewed from PET/CT. The maximum standardized uptake(SUVmax) values were measured. Results: All patients(n:80,mean age 58.0±14.4) had invasive breast carcinoma. Age was significantly related to the presence of lung metastases(p=0.006, mean ages 54y vs 64y).Only liver metastasis had a significant relationship with primary tumor SUVmax values and tumor molecular profile. The patients with HR+/HER2-(7/60 patients, 11.7%) had relatively less liver metastasis than with the other subtypes (9/20patients, 45%). There were significant associations between SUVmax of axillary lymph node(p=0.02), primary tumor(p=0.001), liver metastasis(p=0.02) and tumor subtypes. The numbers of distant metastasis were related with the numbers of axillary lymph node metastasis(p=0.02) and the highest SUVmax of distant metastasis(p=0.001). Discussion: Accurate detection of distant metastases in breast cancer at the time of diagnosis is of great importance in terms of treatment planning and prognosis of the disease. FDG PET/CT is a very reliable modality in determining distant metastasis and their distribution, and as a result of our study, we suggest that PET/CT findings can predict factors with prognostic importance.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"286 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114953417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ş. Balas, Seray Akcalar, K. Yılmaz, M. Akıncı, S. Tokgöz, M. Saydam, M. Akkoca, O. Ergun, H. Karabacak, I. Tatar, B. Hekimoğlu
INTRODUCTION: Ultrasonography (USG) is an imaging technique that enables real-time evaluation of visceral organs via versatile utilization possibilities. Besides diagnosis and treatment contributions, it is crucial in patient follow-up and it also gives an opportunity of intraoperative usage. This study aims to discuss a model of USG training which should be included in the specialist training program and to evaluate the effectiveness of the examination applied to resident doctors and to evaluate the learning curve on patients with thyroid nodule, bile stone stone and intraabdominal free fluid. METHODS: After the ethics committee approving, practical, theoretical training and per-patient usage of USG was given by the radiologist as a part of the clinical training. After the training, four surgical assistants selected from different years of residenties were practiced on a patient basis, under possesion of the radiologist. A twostage examination system was determined and the evaluations of the surgical residents were made by the
{"title":"Ultrasonography Education in General Surgery Resident Training Program and Evaluation of Level of Utrasonography Learning Curves of General Surgery Residents","authors":"Ş. Balas, Seray Akcalar, K. Yılmaz, M. Akıncı, S. Tokgöz, M. Saydam, M. Akkoca, O. Ergun, H. Karabacak, I. Tatar, B. Hekimoğlu","doi":"10.5505/aot.2019.49260","DOIUrl":"https://doi.org/10.5505/aot.2019.49260","url":null,"abstract":"INTRODUCTION: Ultrasonography (USG) is an imaging technique that enables real-time evaluation of visceral organs via versatile utilization possibilities. Besides diagnosis and treatment contributions, it is crucial in patient follow-up and it also gives an opportunity of intraoperative usage. This study aims to discuss a model of USG training which should be included in the specialist training program and to evaluate the effectiveness of the examination applied to resident doctors and to evaluate the learning curve on patients with thyroid nodule, bile stone stone and intraabdominal free fluid. METHODS: After the ethics committee approving, practical, theoretical training and per-patient usage of USG was given by the radiologist as a part of the clinical training. After the training, four surgical assistants selected from different years of residenties were practiced on a patient basis, under possesion of the radiologist. A twostage examination system was determined and the evaluations of the surgical residents were made by the","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114477954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The aim of the current study was to determine the role of PET-CT in the evaluation of bone marrow (BM) involvement during initial staging in patients with newly diagnosed lymphoma. Methods: A retrospective analysis was made of 104 patients who were admitted to our Hematology Department between January 2010 and September 2016 and were diagnosed with lymphoma. Patients were classified as Hodgkin (HL) and Non-Hodgkin Lyphoma (NHL). NHL patients were evaluated in two subgroups as aggressive and indolent. Results: The patients comprised 54 (51.9%) males and 50 (48.1%) females and were classified as 24 patients with HL and 80 with NHL. BM biopsy showed BM involvement in 40 patients (38.5%) and there was no pathological finding in 64 (61.5%) patients. BM involvement was detected on PET-CT in 41 (39.4%) of the whole patient group, of which 26 (63.4%) cases had diffuse infiltration and the remaining 15 (36.6%) cases had patchy infiltration. For all lymphoma patients, sensitivity of PET-CT was 80% and specificity was 85.9%. Sensitivity and specificity of PET-CT was 92.3% and 81.8% for HL patients and 74.1% and 86.8% for NHL patients, respectively. For only aggressive NHL patients, PET-CT sensitivity was 81.8% and specificity was 87.75%. Discussion and Conclusion: PET-CT is an effective method for assessing BM involvement with a higher sensitivity especially for HL and aggressive NHL patients in detecting patchy involvement. The fact that it is non-invasive and easy to apply may support that it can be used instead of BM biopsy.
{"title":"The Predictive Value of FDG PET/CT in the Evaluation of Bone Marrow Involvement in Lymphoma Patients","authors":"B. Sağlam, A. Yıldız, B. Kaya, Kultigin Türkmen","doi":"10.5505/aot.2022.39259","DOIUrl":"https://doi.org/10.5505/aot.2022.39259","url":null,"abstract":"Introduction: The aim of the current study was to determine the role of PET-CT in the evaluation of bone marrow (BM) involvement during initial staging in patients with newly diagnosed lymphoma. Methods: A retrospective analysis was made of 104 patients who were admitted to our Hematology Department between January 2010 and September 2016 and were diagnosed with lymphoma. Patients were classified as Hodgkin (HL) and Non-Hodgkin Lyphoma (NHL). NHL patients were evaluated in two subgroups as aggressive and indolent. Results: The patients comprised 54 (51.9%) males and 50 (48.1%) females and were classified as 24 patients with HL and 80 with NHL. BM biopsy showed BM involvement in 40 patients (38.5%) and there was no pathological finding in 64 (61.5%) patients. BM involvement was detected on PET-CT in 41 (39.4%) of the whole patient group, of which 26 (63.4%) cases had diffuse infiltration and the remaining 15 (36.6%) cases had patchy infiltration. For all lymphoma patients, sensitivity of PET-CT was 80% and specificity was 85.9%. Sensitivity and specificity of PET-CT was 92.3% and 81.8% for HL patients and 74.1% and 86.8% for NHL patients, respectively. For only aggressive NHL patients, PET-CT sensitivity was 81.8% and specificity was 87.75%. Discussion and Conclusion: PET-CT is an effective method for assessing BM involvement with a higher sensitivity especially for HL and aggressive NHL patients in detecting patchy involvement. The fact that it is non-invasive and easy to apply may support that it can be used instead of BM biopsy.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133835319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bedriye Busra Demirel, Hüseyin Emre Tosun, Gülin Uçmak
Introduction: We aimed to investigate the relation between primary tumor and axillary lymph node maximum standardized uptake values (SUVmax) with the presence of distant metastases at initial staging of breast cancer. Materials and Methods: Fifty-seven women who were referred to our clinic for staging positron emission tomography/computed tomography (PET/CT) with diagnosis of breast cancer were included in the study. Immunohistochemical (IHC) features of the primary tumor [hormone receptor (HR), human epidermal growth factor receptor type-2 (HER2), Ki67 index] were reviewed retrospectively. All patients’ HR status was positive and HER2 status was negative. Primary tumor SUVmax (Tmax) and axillary lymph node SUVmax (Nmax) values and primary tumor-to-axillary lymph node (T/N) ratios were calculated in PET/CT. Patients were divided into two groups as metastatic and non-metastatic according to PET/CT findings. The differences between groups in terms of age, Ki67 index and SUV values were statistically analyzed. Results: The mean age of the patients was 52±14.4 (range 25-79 years). According to PET/CT findings, the patients were divided in two groups, 57% metastatic (n = 33) and 43% non-metastatic (n = 24). While no statistically significant difference was observed between the two groups in terms of age, Ki67 index and Tmax averages, statistically significant differences were found between Nmax values (p <0.001) and T/N ratios (p=0.001). Cut-off value in association with distant metastasis was 7,8 for Nmax value and 8,5 for T/N ratio on ROC curve analysis. Discussion: Accurate staging is important in terms of treatment plan and prediction of disease prognosis in breast cancer. In our study, it was thought that the difference in Nmax values and T/N ratios, independent of Tmax values, could be a determinant in terms of the overlooked and possible early metastatic disease indicator in the patient group without known distant metastasis.
{"title":"The Relation Between Tumor and Axillary Lymph Node SUV Values with the Presence of Distant Metastases in Staging F18 FDG PET/CT in Breast Cancer","authors":"Bedriye Busra Demirel, Hüseyin Emre Tosun, Gülin Uçmak","doi":"10.5505/aot.2022.75688","DOIUrl":"https://doi.org/10.5505/aot.2022.75688","url":null,"abstract":"Introduction: We aimed to investigate the relation between primary tumor and axillary lymph node maximum standardized uptake values (SUVmax) with the presence of distant metastases at initial staging of breast cancer. Materials and Methods: Fifty-seven women who were referred to our clinic for staging positron emission tomography/computed tomography (PET/CT) with diagnosis of breast cancer were included in the study. Immunohistochemical (IHC) features of the primary tumor [hormone receptor (HR), human epidermal growth factor receptor type-2 (HER2), Ki67 index] were reviewed retrospectively. All patients’ HR status was positive and HER2 status was negative. Primary tumor SUVmax (Tmax) and axillary lymph node SUVmax (Nmax) values and primary tumor-to-axillary lymph node (T/N) ratios were calculated in PET/CT. Patients were divided into two groups as metastatic and non-metastatic according to PET/CT findings. The differences between groups in terms of age, Ki67 index and SUV values were statistically analyzed. Results: The mean age of the patients was 52±14.4 (range 25-79 years). According to PET/CT findings, the patients were divided in two groups, 57% metastatic (n = 33) and 43% non-metastatic (n = 24). While no statistically significant difference was observed between the two groups in terms of age, Ki67 index and Tmax averages, statistically significant differences were found between Nmax values (p <0.001) and T/N ratios (p=0.001). Cut-off value in association with distant metastasis was 7,8 for Nmax value and 8,5 for T/N ratio on ROC curve analysis. Discussion: Accurate staging is important in terms of treatment plan and prediction of disease prognosis in breast cancer. In our study, it was thought that the difference in Nmax values and T/N ratios, independent of Tmax values, could be a determinant in terms of the overlooked and possible early metastatic disease indicator in the patient group without known distant metastasis.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"315 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133807432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: In this study, we aimed to present the results of patients who underwent prophylactic intramedullary fixation for benign bone lesions. Materials and Methods: Twenty-two patients who underwent curettage, grafting and prophylactic intramedullary fixation for benign bone lesions between 2008 and 2017 were included in this study. The lesions were examined according to the Mirels’ classification in the preoperative period and the pathological fracture risk was determined. Curettage, allografting and intramedullary fixation were used in the treatment of all patients. In the follow-up examination, patients were evaluated according to the range of motion, pain, radiological appearance of the lesion and the implant. Results: The mean age of the patients was 24.8 (7-38) years. The mean follow-up period was 35.8 (13-80) months. The initial complaint of twenty-one patients was pain which caused loss of function in two patients. One patient with pathological humerus fracture was admitted with acute pain and loss of function. He was followed conservatively for two months, then prophylactic surgery was performed. The mean Mirels’ score of the patients was 9.3 (9-10). In the follow-up examination, the range of motion was full in all patients. The mean VAS score decreased from 8.09 to 2.54 postoperatively. Conclusions: We conclude that prophylactic fixation for benign bone lesions which has 9 or more Mirels’ score reduces the risk of impending pathological fractures, reduces VAS scores, and also prevents loss of function and enables to return normal activity earlier.
{"title":"Outcomes of prophylactic intramedullary fixation for benign bone lesions","authors":"Çağrı Neyişci, Y. Erdem, A. Bilekli","doi":"10.5505/aot.2019.64325","DOIUrl":"https://doi.org/10.5505/aot.2019.64325","url":null,"abstract":"Background: In this study, we aimed to present the results of patients who underwent prophylactic intramedullary fixation for benign bone lesions. Materials and Methods: Twenty-two patients who underwent curettage, grafting and prophylactic intramedullary fixation for benign bone lesions between 2008 and 2017 were included in this study. The lesions were examined according to the Mirels’ classification in the preoperative period and the pathological fracture risk was determined. Curettage, allografting and intramedullary fixation were used in the treatment of all patients. In the follow-up examination, patients were evaluated according to the range of motion, pain, radiological appearance of the lesion and the implant. Results: The mean age of the patients was 24.8 (7-38) years. The mean follow-up period was 35.8 (13-80) months. The initial complaint of twenty-one patients was pain which caused loss of function in two patients. One patient with pathological humerus fracture was admitted with acute pain and loss of function. He was followed conservatively for two months, then prophylactic surgery was performed. The mean Mirels’ score of the patients was 9.3 (9-10). In the follow-up examination, the range of motion was full in all patients. The mean VAS score decreased from 8.09 to 2.54 postoperatively. Conclusions: We conclude that prophylactic fixation for benign bone lesions which has 9 or more Mirels’ score reduces the risk of impending pathological fractures, reduces VAS scores, and also prevents loss of function and enables to return normal activity earlier.","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116214147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Simultaneous Evaluation of Serum Immunofixation Electrophoresis and Serum Free Light Chain Measurements Used in the Diagnosis of Monoclonal Gammopathy and Smoldering Multiple Myeloma of Uncertain Significance in the Presence of Risk Factors","authors":"İrem Öner, Fatih Saçkan, A. Ünal","doi":"10.5505/aot.2023.32650","DOIUrl":"https://doi.org/10.5505/aot.2023.32650","url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125215349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：